Literature DB >> 21153187

Dexamethasone promotes von kossa-positive nodule formation and increased alkaline phosphatase activity in costochondral chondrocyte cultures.

Z Schwartz1, R H Hancock, D D Dean, B P Brooks, R Gomez, A L Boskey, G Balian, B D Boyan.   

Abstract

This study examined the effect of dexamethasone on von Kossa-positive nodule formation and alkaline phosphate specific activity of costochondral chondrocytes at two distinct stages of maturation. The nodules formed by the more mature growth zone chondrocyte cultures contained von Kossa-positive deposits in the extracellular matrix that had a punctate morphology. The nodules formed by the less mature resting zone cells also contained von Kossa-positive deposits, but differentiation was delayed by three-to-five days compared to the growth zone cell cultures. Dexamethasone stimulated the number of nodules formed and shortened the length of time required for von Kossa-positive nodule formation in both types of cultures. During the first 48 h of exposure to dexamethasone, alkaline phosphatase specific activity in the cell layer of both resting zone and growth zone cultures was increased in a dose-dependent manner. At 12 days post-confluence and thereafter, enzyme activity was inhibited in the dexamethasone-treated cultures. Changes in matrix vesicle alkaline phosphatase specific activity reflected those changes seen in the cell layer after dexamethasone treatment, but with higher magnitude, suggesting that one effect of dexamethasone might be to regulate matrix vesicle function. With the exception of one culture, the chondrocytes did not synthesize type X collagen under any of the experimental conditions used. Fourier transform infrared spectroscopy (FTIR) failed to detect the presence of calcium phosphates in any of the cultures exposed to dexamethasone except one. These results demonstrate that dexamethasone promotes early differentiation events, including nodule formation and increased alkaline phosphatase activity, in costochondral chondrocyte cultures. The failure to detect type X collagen synthesis and mineralization in both dexamamethasone-treated and control cultures suggests that these cultures lack the factors necessary for terminal differentiation and mineralization.

Entities:  

Year:  1995        PMID: 21153187     DOI: 10.1007/BF03021418

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  62 in total

1.  Glucocorticoid inhibition of sulfate incorporation by cartilage of normal rats.

Authors:  R H Tessler; W D Salmon
Journal:  Endocrinology       Date:  1975-04       Impact factor: 4.736

2.  Stimulation by glucocorticoid of the synthesis of cartilage-matrix proteoglycans produced by rabbit costal chondrocytes in vitro.

Authors:  Y Kato; D Gospodarowicz
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

3.  Cortisol modulation of osteoblast metabolic activity in cultured neonatal rat bone.

Authors:  T J Hahn; S L Westbrook; L R Halstead
Journal:  Endocrinology       Date:  1984-05       Impact factor: 4.736

4.  Studies of mineralization in tissue culture: optimal conditions for cartilage calcification.

Authors:  A L Boskey; D Stiner; S B Doty; I Binderman; P Leboy
Journal:  Bone Miner       Date:  1992-01

5.  Differential expression of phenotype by resting zone and growth region costochondral chondrocytes in vitro.

Authors:  B D Boyan; Z Schwartz; L D Swain; D L Carnes; T Zislis
Journal:  Bone       Date:  1988       Impact factor: 4.398

6.  Clonal growth of primary cultures of human hyaline chondrocytes in a defined medium.

Authors:  S D Jennings; R G Ham
Journal:  Cell Biol Int Rep       Date:  1983-02

7.  Morphometric study of cartilage dynamics in the chick embryo tibia. II. Dexamethasone-treated embryos.

Authors:  F B Ranz; J Aceitero; F Gaytan
Journal:  J Anat       Date:  1987-10       Impact factor: 2.610

8.  The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro.

Authors:  B D Boyan; Z Schwartz; D L Carnes; V Ramirez
Journal:  Endocrinology       Date:  1988-06       Impact factor: 4.736

9.  Localization of vitamin D3-responsive alkaline phosphatase in cultured chondrocytes.

Authors:  Z Schwartz; G Knight; L D Swain; B D Boyan
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

10.  A disulfide-bonded short chain collagen synthesized by degenerative and calcifying zones of bovine growth plate cartilage.

Authors:  W T Grant; M D Sussman; G Balian
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

View more
  5 in total

1.  Osteogenic Differentiation of Mesenchymal Stem Cells by Mimicking the Cellular Niche of the Endochondral Template.

Authors:  Fiona E Freeman; Hazel Y Stevens; Peter Owens; Robert E Guldberg; Laoise M McNamara
Journal:  Tissue Eng Part A       Date:  2016-09-28       Impact factor: 3.845

2.  The effects of 17 beta-estradiol on chondrocyte differentiation are modulated by vitamin D3 metabolites.

Authors:  Z Schwartz; Y Finer; E Nasatzky; W A Soskolne; D D Dean; B D Boyan; A Ornoy
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

3.  Parathyroid hormone and transforming growth factor-beta1 coregulate chondrocyte differentiation in vitro.

Authors:  E Nasatzky; E Azran; D D Dean; B D Boyan; Z Schwartz
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

4.  Platelet derived growth factor stimulates chondrocyte proliferation but prevents endochondral maturation.

Authors:  K Kieswetter; Z Schwartz; M Alderete; D D Dean; B D Boyan
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

5.  Treatment of resting zone chondrocytes with bone morphogenetic protein-2 induces maturation into a phenotype characteristic of growth zone chondrocytes by downregulating responsiveness to 24,25(OH)2D3 and upregulating responsiveness to 1,25-(OH)2D3.

Authors:  Z Schwartz; V L Sylvia; Y Liu; D D Dean; B D Boyan
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.